•A decrease of ≥14% of serum CEA level from baseline had 90% specificity for overall tumor response making it a promising tool and a more objective method of evaluating response to chemotherapy in advanced NSCLC patients. Here, CEACAM5 is linked to non-small cell lung carcinoma.